Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery
Clinical trial NCT06745492 · COMPLETED
Trial details
- NCT number
- NCT06745492
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-08-20
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.